BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37298689)

  • 1. Tumoricidal Activity of Simvastatin in Synergy with RhoA Inactivation in Antimigration of Clear Cell Renal Cell Carcinoma Cells.
    Lee YG; Chou FN; Tung SY; Chou HC; Ko TL; Fann YC; Juan SH
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases.
    Zhu Y; Casey PJ; Kumar AP; Pervaiz S
    Cell Death Dis; 2013 Apr; 4(4):e568. PubMed ID: 23559002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.
    Al-Haidari AA; Syk I; Thorlacius H
    Biochem Biophys Res Commun; 2014 Mar; 446(1):68-72. PubMed ID: 24582560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
    Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
    Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway.
    Woschek M; Kneip N; Jurida K; Marzi I; Relja B
    Nutr Cancer; 2016; 68(3):420-7. PubMed ID: 27042994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin reduces lipoprotein-associated phospholipase A2 in lipopolysaccharide-stimulated human monocyte-derived macrophages through inhibition of the mevalonate-geranylgeranyl pyrophosphate-RhoA-p38 mitogen-activated protein kinase pathway.
    Song JX; Ren JY; Chen H
    J Cardiovasc Pharmacol; 2011 Feb; 57(2):213-22. PubMed ID: 21052011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
    Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
    Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
    Lee MH; Cho YS; Han YM
    Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA.
    Porter KE; Turner NA; O'Regan DJ; Balmforth AJ; Ball SG
    Cardiovasc Res; 2004 Mar; 61(4):745-55. PubMed ID: 14985071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells.
    Alizadeh J; Zeki AA; Mirzaei N; Tewary S; Rezaei Moghadam A; Glogowska A; Nagakannan P; Eftekharpour E; Wiechec E; Gordon JW; Xu FY; Field JT; Yoneda KY; Kenyon NJ; Hashemi M; Hatch GM; Hombach-Klonisch S; Klonisch T; Ghavami S
    Sci Rep; 2017 Mar; 7():44841. PubMed ID: 28344327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
    Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
    Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of simvastatin on migration and invasion of rheumatoid fibroblast-like synoviocytes by preventing geranylgeranylation of RhoA.
    Xiao Y; Liang L; Pan Y; Lian F; Li L; Lin H; Fu D; Fan J; Yang X; Sun L; Xu H
    Rheumatol Int; 2013 Feb; 33(2):389-99. PubMed ID: 22451024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.
    Tang D; Park HJ; Georgescu SP; Sebti SM; Hamilton AD; Galper JB
    Life Sci; 2006 Sep; 79(15):1484-92. PubMed ID: 16740276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition.
    Serra N; Rosales R; Masana L; Vallvé JC
    PLoS One; 2015; 10(7):e0133875. PubMed ID: 26207907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Variants in Caveolin-1 and RhoA/ROCK1 Are Associated with Clear Cell Renal Cell Carcinoma Risk in a Chinese Population.
    Zhao R; Liu K; Huang Z; Wang J; Pan Y; Huang Y; Deng X; Liu J; Qin C; Cheng G; Hua L; Li J; Yin C
    PLoS One; 2015; 10(6):e0128771. PubMed ID: 26066055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation.
    Chang CC; Huang KH; Hsu SP; Lee YG; Sue YM; Juan SH
    Sci Rep; 2019 Mar; 9(1):4606. PubMed ID: 30872677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer.
    Chen MC; Tsai YC; Tseng JH; Liou JJ; Horng S; Wen HC; Fan YC; Zhong WB; Hsu SP
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
    Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
    Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer.
    Greenaway JB; Virtanen C; Osz K; Revay T; Hardy D; Shepherd T; DiMattia G; Petrik J
    Oncotarget; 2016 Jul; 7(30):47343-47365. PubMed ID: 27329838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.